Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Gerodorm: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Gerodorm - General Information

Gerodorm is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Gerodorm is not approved for sale in the United States or Canada.

 

Pharmacology of Gerodorm

Gerodorm is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Gerodorm is not approved for sale in the United States or Canada.

 

Additional information about Gerodorm

Gerodorm Indication: For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Mechanism Of Action: Gerodorm binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways. Drug Interactions: Not Available Food Interactions: Avoid alcohol.Take with food.Avoid excessive quantities of coffee or tea (Caffeine). Generic Name: Cinolazepam Synonyms: Cinolazepamum [inn-latin] Drug Category: Anticonvulsants; Sedatives and Hypnotics; Benzodiazepines Drug Type: Small Molecule; Approved Other Brand Names containing Cinolazepam: Gerodorm; Absorption: Bioavailability following oral administration is 90-100%. Toxicity (Overdose): The onset of impairment of consciousness is relatively rapid in benzodiazepine poisoning. Onset is more rapid following larger doses and with agents of shorter duration of action. The most common and initial symptom is somnolence. This may progress to coma Grade I or Grade II following very large ingestions. Protein Binding: Not Available Biotransformation: Hepatic. Half Life: 9 hours Dosage Forms of Gerodorm: Not Available Chemical IUPAC Name: 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-3H-1,4-benzodiazepin-1-yl]propanenitrile Chemical Formula: C18H13ClFN3O2 Cinolazepam on Wikipedia: https://en.wikipedia.org/wiki/Cinolazepam Organisms Affected: Humans and other mammals